Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
8.71
0.00 (0.00%)
At close: May 12, 2025, 4:00 PM
8.69
-0.02 (-0.23%)
After-hours: May 12, 2025, 7:56 PM EDT
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $2.26 billion as of May 12, 2025. Its market cap has decreased by -52.66% in one year.
Market Cap
2.26B
Enterprise Value
10.67B
1-Year Change
-52.66%
Ranking
Category
Stock Price
$8.71
Market Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $2.26B, a decrease of -73.10%. That is a compound annual growth rate of -28.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 2.26B | -41.07% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |